Catherine Mummery

8PUBLICATIONS
86CO-AUTHORS
AutoimmunityMechanobiologyMedical devicesBiologically active moleculesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.

|Mar 05, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial.

Catherine J Mummery, Arthur J Mayorga, Adam Simmons

|Feb 11, 2026
Exploratory analyses of clinical outcomes from the BIIB080 phase 1b study in mild Alzheimer's disease.

Melanie Shulman, Shuang Wu, Nick Ziogas

|Dec 13, 2025
Lecanemab appropriate use recommendations for clinical practice in the UK.

Catherine J Mummery, Jill Rasmussen, Dan Blackburn

|Feb 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.

Randall J Bateman, Yan Li, Eric M McDade

|Apr 24, 2023
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn

Pageof 2

Frequent Collaborators

2 joint publications

Simon Ducharme

2 joint publications

Juha O Rinne

2 joint publications

Eric E Swayze

2 joint publications

Daniel A Norris